A Method for the Detection and Management of Adverse Events in Clinical Trials

作者: Joseph A. Tangrea , Maria Elena Adrianza , Mary McAdams

DOI: 10.1177/009286159102500108

关键词:

摘要: This paper describes a systematic approach to the detection, classification, and documentation of adverse events in multicenter clinical trial. The system is designed minimize investigator prejudgment, capture infrequent or unexpected effects, track concurrent events, allow for comparison effects across centers. method employs standard questionnaire, which records health status symptomatology patient at study entry as well follow-up visits comparison. A systems review, detect emerging changing symptoms, also included. association drug classified according criteria. All whether not judged be related, are recorded. Dose modifications prescribed documented each visit until event resolved. combines methodology with continuous monitoring provide comprehensive managing event...

参考文章(46)
Abraham G. Hartzema, Miquel S. Porta, Hugh H. Tilson, Audrey Smith Rogers, Adverse Drug Events: Identification and Attribution: Annals of Pharmacotherapy. ,vol. 21, pp. 915- 920 ,(1987) , 10.1177/106002808702101114
Sjövall J, Wallin J, Detection of adverse drug reactions in a clinical trial using two types of questioning. Clinical Therapeutics. ,vol. 3, pp. 450- ,(1981)
Jeffrey L. Carson, Brian L. Strom, Techniques of Postmarketing Surveillance Medical toxicology. ,vol. 1, pp. 237- 246 ,(1986) , 10.1007/BF03259840
L Lasagna, Bias in the elucidation of subjective side‐effects. British Journal of Clinical Pharmacology. ,vol. 11, ,(1981) , 10.1111/J.1365-2125.1981.TB01846.X
Lortie Fm, Postmarketing surveillance of adverse drug reactions: problems and solutions. Canadian Medical Association Journal. ,vol. 135, pp. 27- 32 ,(1986)
MS Kramer, Difficulties in assessing the adverse effects of drugs. British Journal of Clinical Pharmacology. ,vol. 11, ,(1981) , 10.1111/J.1365-2125.1981.TB01845.X
B. Westerholm, The rationale for a post-marketing surveillance Human Reproduction. ,vol. 2, pp. 41- 44 ,(1987) , 10.1093/OXFORDJOURNALS.HUMREP.A136486
J. Koch-Weser, E. M. Sellers, R. Zacest, The ambiguity of adverse drug reactions. European Journal of Clinical Pharmacology. ,vol. 11, pp. 75- 78 ,(1977) , 10.1007/BF00562895
D.J. Finney, THE DESIGN AND LOGIC OF A MONITOR OF DRUG USE. Journal of Chronic Diseases. ,vol. 18, pp. 77- 98 ,(1965) , 10.1016/0021-9681(65)90054-8